Log in to save to my catalogue

Whole-body MRI evaluation in neurofibromatosis type 1 patients younger than 3 years old and the gene...

Whole-body MRI evaluation in neurofibromatosis type 1 patients younger than 3 years old and the gene...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_041f375cafe442138a157d9b8b018133

Whole-body MRI evaluation in neurofibromatosis type 1 patients younger than 3 years old and the genetic contribution to disease progression

About this item

Full title

Whole-body MRI evaluation in neurofibromatosis type 1 patients younger than 3 years old and the genetic contribution to disease progression

Publisher

England: BioMed Central Ltd

Journal title

Orphanet journal of rare diseases, 2022-01, Vol.17 (1), p.24-24, Article 24

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Neurofibromatosis type 1 (NF1) is a common human genetic disease with age-dependent phenotype progression. The overview of clinical and radiological findings evaluated by whole-body magnetic resonance imaging (WBMRI) in NF1 patients < 3 years old assessed with a genetic contribution to disease progression is presented herein.
This study included...

Alternative Titles

Full title

Whole-body MRI evaluation in neurofibromatosis type 1 patients younger than 3 years old and the genetic contribution to disease progression

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_041f375cafe442138a157d9b8b018133

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_041f375cafe442138a157d9b8b018133

Other Identifiers

ISSN

1750-1172

E-ISSN

1750-1172

DOI

10.1186/s13023-022-02174-3

How to access this item